**Core Concept**
Phenobarbitone is a barbiturate that acts as an anticonvulsant and sedative by modulating the activity of certain enzymes and ion channels in the nervous system. One of its primary mechanisms of action is through the inhibition of the electron transport chain (ETC) in mitochondria.

**Why the Correct Answer is Right**
Phenobarbitone is known to inhibit the NADH:ubiquinone oxidoreductase (Complex I) of the electron transport chain. This inhibition occurs due to the binding of phenobarbitone to the flavin mononucleotide (FMN) and iron-sulfur clusters within the complex, thereby reducing the activity of the complex and impairing the transfer of electrons from NADH to ubiquinone. This mechanism of action contributes to the anticonvulsant and sedative effects of phenobarbitone.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because Complex II (succinate dehydrogenase) is not directly inhibited by phenobarbitone.
* **Option B:** This option is incorrect because Complex III (cytochrome b-c1 complex) is not the primary target of phenobarbitone's inhibitory action.
* **Option D:** This option is incorrect because Complex IV (cytochrome oxidase) is not directly affected by phenobarbitone.

**Clinical Pearl / High-Yield Fact**
Phenobarbitone's ability to inhibit Complex I of the ETC is a key factor in its anticonvulsant action, making it a useful treatment for certain types of seizures. However, its sedative effects and potential for dependence must be carefully managed.

**Correct Answer: C. Complex I.